William Garrett Gray Checkpoint Therapeutics, Inc. (CKPT) insider trading activity

William Garrett Gray is Chief Financial Officer of Checkpoint Therapeutics, Inc.. Currently has a direct ownership of 1.45 Million shares of CKPT, which is worth approximately $5.84 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 12,322 shares (Common Stock) at a price of $4.05 per share, resulting in proceeds of $49,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M

40.05% 3M change

895.92% 12M change

Total Value Held $5.84 Million

WILLIAM GARRETT GRAY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	SELL Open market or private sale	$49,904 $4.05 p/Share	12,322 Reduced 0.84%	1,446,322 Common Stock
Feb 06 2025	SELL Open market or private sale	$271,983 $3.67 p/Share	74,110 Reduced 4.84%	1,458,644 Common Stock
Jan 30 2025	BUY Grant, award, or other acquisition	-	500,000 Added 24.6%	1,532,754 Common Stock (restricted)
Dec 18 2024	SELL Open market or private sale	$1,076,412 $4.01 p/Share	268,432 Reduced 20.63%	1,032,754 Common Stock
Dec 13 2024	BUY Grant, award, or other acquisition	-	629,000 Added 32.59%	1,301,186 Common Stock
Jun 26 2024	SELL Open market or private sale	$26,858 $2.06 p/Share	13,038 Reduced 1.9%	672,186 Common Stock
May 24 2024	BUY Grant, award, or other acquisition	-	540,000 Added 44.07%	685,224 Common Stock (restricted)
Feb 28 2024	SELL Open market or private sale	$4,212 $2.07 p/Share	2,035 Reduced 1.38%	145,224 Common Stock
Feb 01 2024	SELL Open market or private sale	$8,024 $1.95 p/Share	4,115 Reduced 2.72%	147,259 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	100,000 Added 39.78%	151,374 Common Stock (restricted)
Mar 02 2023	SELL Open market or private sale	$17,955 $5.0 p/Share	3,591 Reduced 6.53%	51,374 Common Stock
Feb 27 2023	SELL Open market or private sale	$8,919 $4.66 p/Share	1,914 Reduced 3.88%	47,465 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	7,500 Added 12.01%	54,965 Common Stock
Feb 01 2023	SELL Open market or private sale	$15,107 $4.79 p/Share	3,154 Reduced 6.0%	49,379 Common Stock
Jan 10 2023	SELL Open market or private sale	$12,541 $6.75 p/Share	1,858 Reduced 3.42%	52,533 Common Stock
Mar 10 2022	SELL Open market or private sale	$72,192 $1.89 p/Share	38,197 Reduced 6.56%	543,910 Common Stock
Feb 01 2022	SELL Open market or private sale	$93,028 $2.51 p/Share	37,063 Reduced 5.99%	582,107 Common Stock
Jan 31 2022	BUY Grant, award, or other acquisition	-	137,000 Added 18.12%	619,170 Common Stock (restricted)
Feb 04 2021	SELL Open market or private sale	$96,331 $3.66 p/Share	26,320 Reduced 5.18%	482,170 Common Stock
Jan 06 2021	BUY Grant, award, or other acquisition	-	151,000 Added 22.9%	508,490 Common Stock (restricted)
Dec 22 2020	SELL Open market or private sale	$6,713 $2.79 p/Share	2,406 Reduced 0.67%	357,490 Common Stock

WGG

William Garrett Gray

Chief Financial Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CKPT shares.

Notify only if

Value

Insider Trading

Get notified when an Checkpoint Therapeutics, Inc. insider buys or sells CKPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Checkpoint Therapeutics, Inc.

Track Activities on CKPT

Account